216 related articles for article (PubMed ID: 33017204)
1. Seroprevalence for vaccine-preventable diseases among Italian healthcare workers.
Coppeta L; D'Alessandro I; Pietroiusti A; Somma G; Balbi O; Iannuzzi I; Magrini A
Hum Vaccin Immunother; 2021 May; 17(5):1342-1346. PubMed ID: 33017204
[TBL] [Abstract][Full Text] [Related]
2. Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011.
Taddei C; Ceccherini V; Niccolai G; Porchia BR; Boccalini S; Levi M; Tiscione E; Santini MG; Baretti S; Bonanni P; Bechini A
Hum Vaccin Immunother; 2014; 10(9):2612-22. PubMed ID: 25483489
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia.
Almuneef MA; Memish ZA; Balkhy HH; Otaibi B; Helmi M
Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1178-83. PubMed ID: 17080374
[TBL] [Abstract][Full Text] [Related]
4. Seroepidemiology of hepatitis viruses, measles, mumps, rubella and varicella among healthcare workers and students: Should we screen before vaccination?
Karadeniz A; Akduman Alaşehir E
J Infect Public Health; 2020 Apr; 13(4):480-484. PubMed ID: 32113699
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy.
Kumakura S; Shibata H; Onoda K; Nishimura N; Matsuda C; Hirose M
Epidemiol Infect; 2014 Jan; 142(1):12-9. PubMed ID: 23574767
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan.
Asari S; Deguchi M; Tahara K; Taniike M; Toyokawa M; Nishi I; Watanabe M; Iwatani Y; Makimoto K
Am J Infect Control; 2003 May; 31(3):157-62. PubMed ID: 12734521
[TBL] [Abstract][Full Text] [Related]
7. Prevaccination antibody screening and immunization program for healthcare personnel against measles, mumps, rubella, and varicella in a Japanese tertiary care hospital.
Kanamori H; Tokuda K; Ikeda S; Endo S; Ishizawa C; Hirai Y; Takahashi M; Aoyagi T; Hatta M; Gu Y; Yano H; Weber DJ; Kaku M
Tohoku J Exp Med; 2014 Oct; 234(2):111-6. PubMed ID: 25224029
[TBL] [Abstract][Full Text] [Related]
8. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?
Celikbas A; Ergonul O; Aksaray S; Tuygun N; Esener H; Tanir G; Eren S; Baykam N; Guvener E; Dokuzoguz B
Am J Infect Control; 2006 Nov; 34(9):583-7. PubMed ID: 17097453
[TBL] [Abstract][Full Text] [Related]
9. Pre-vaccination IgG screening for mumps is the most cost-effectiveness immunization strategy among Health Care Workers.
Coppeta L; Balbi O; Baldi S; Pietroiusti A; Magrini A
Hum Vaccin Immunother; 2019; 15(5):1135-1138. PubMed ID: 30779686
[TBL] [Abstract][Full Text] [Related]
10. Impact of vaccination on measles, mumps, and rubella antibody titers in Japanese healthcare workers: An observational study.
Ogawa T; Inoue T; Kasahara K; Konishi M; Mikasa K
PLoS One; 2020; 15(3):e0230329. PubMed ID: 32208432
[TBL] [Abstract][Full Text] [Related]
11. Rubella Immunity among Italian Female Healthcare Workers: A Serological Study.
Coppeta L; Ferrari C; Iannuzzi I; D'Alessandro I; Balbi O; Pietroiusti A; Trabucco Aurilio M
Int J Environ Res Public Health; 2020 Oct; 17(21):. PubMed ID: 33143150
[TBL] [Abstract][Full Text] [Related]
12. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save?
Alp E; Cevahir F; Gökahmetoglu S; Demiraslan H; Doganay M
J Infect Public Health; 2012 Apr; 5(2):127-32. PubMed ID: 22541258
[TBL] [Abstract][Full Text] [Related]
13. [Seroprevalence of measles, rubella, mumps and varicella in health workers in the Community of Madrid].
Rodríguez ML; Martínez D; Santos-Sancho JM; Borda JR; Orero A
Rev Esp Quimioter; 2014 Jun; 27(2):98-101. PubMed ID: 24940889
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan.
Hatakeyama S; Moriya K; Itoyama S; Nukui Y; Uchida M; Shintani Y; Morisawa Y; Kimura S
Infect Control Hosp Epidemiol; 2004 Jul; 25(7):591-4. PubMed ID: 15301032
[TBL] [Abstract][Full Text] [Related]
15. Immunity to vaccine-preventable diseases among paediatric healthcare workers in Denmark, 2019.
von Linstow ML; Yde Nielsen A; Kirkby N; Eltvedt A; Nordmann Winther T; Bybeck Nielsen A; Bang D; Poulsen A
Euro Surveill; 2021 Apr; 26(17):. PubMed ID: 33928900
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of vaccine-preventable and non-vaccine-preventable infections in migrants in Spain.
Norman FF; Comeche B; Martínez-Lacalzada M; Pérez-Molina JA; Gullón B; Monge-Maillo B; Chamorro S; López-Vélez R
J Travel Med; 2021 Jun; 28(4):. PubMed ID: 33611577
[TBL] [Abstract][Full Text] [Related]
17. Self-reported histories of disease and vaccination against measles, mumps, rubella and varicella in health care personnel in Japan.
Kumakura S; Onoda K; Hirose M
J Infect Chemother; 2014 Mar; 20(3):194-8. PubMed ID: 24462433
[TBL] [Abstract][Full Text] [Related]
18. Coverage rates against vaccine-preventable diseases among healthcare workers in Sicily (Italy).
Ledda C; Rapisarda V; Maltezou HC; Contrino E; Conforto A; Maida CM; Tramuto F; Vitale F; Costantino C
Eur J Public Health; 2021 Feb; 31(1):56. PubMed ID: 33001212
[TBL] [Abstract][Full Text] [Related]
19. Performance Characteristics of a Multiplex Flow Immunoassay for Detection of IgG-Class Antibodies to Measles, Mumps, Rubella, and Varicella-Zoster Viruses in Presumptively Immune Health Care Workers.
Theel ES; Sorenson M; Rahman C; Granger D; Vaughn A; Breeher L
J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 32024728
[TBL] [Abstract][Full Text] [Related]
20. Vaccine-preventable diseases: Immune response in a large population of healthcare students.
Santoro PE; Paladini A; Borrelli I; Amantea C; Rossi MF; Fortunato C; Gualano MR; Marchetti A; Cadeddu C; Moscato U
Vaccine; 2024 Feb; 42(4):930-936. PubMed ID: 38246845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
